As of my last update in October 2023, there is limited publicly available information regarding the chemical substance AVLX-125, identified by the CAS number 1786434-31-8. This compound may be a novel or proprietary substance, possibly related to pharmaceutical or biochemical research. Typically, substances like this may exhibit specific characteristics such as molecular weight, solubility, stability, and reactivity, which are crucial for understanding their potential applications and safety profiles. Additionally, the compound may have undergone various studies to assess its efficacy, toxicity, and mechanism of action, particularly if it is being investigated for therapeutic use. For detailed and specific characteristics, including its chemical structure, biological activity, and regulatory status, consulting scientific literature or databases that specialize in chemical substances would be necessary. Always ensure to refer to the latest research or official sources for the most accurate and comprehensive information.

AVLX-125

1786434-31-8: As of my last update in October 2023, there is limited publicly available information regarding the chemical substance AVLX-125, identified by the CAS number 1786434-31-8. This compound may be a novel or proprietary substance, possibly related to pharmaceutical or biochemical research. Typically, substances like this may exhibit specific characteristics such as molecular weight, solubility, stability, and reactivity, which are crucial for understanding their potential applications and safety profiles. Additionally, the compound may have undergone various studies to assess its efficacy, toxicity, and mechanism of action, particularly if it is being investigated for therapeutic use. For detailed and specific characteristics, including its chemical structure, biological activity, and regulatory status, consulting scientific literature or databases that specialize in chemical substances would be necessary. Always ensure to refer to the latest research or official sources for the most accurate and comprehensive information.

<p>AVLX-125 (UCCB01-125), a potent inhibitor of PSD-95 and PDZ domains, exhibits a dissociation constant (Kd) of 10 nM. It is utilized in researching inflammatory pain [1] [2].</p>

CAS 1786434-31-8

AVLX-125

AVLX-125

Ref: TM-TP2548